实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2014年
4期
406-408
,共3页
乳腺癌%糖类抗原15-3%糖类抗原125%癌胚抗原%联合检测
乳腺癌%糖類抗原15-3%糖類抗原125%癌胚抗原%聯閤檢測
유선암%당류항원15-3%당류항원125%암배항원%연합검측
Breast cancer%Carbohydrate antigen 15-3%Carbohydrate antigen 125%Carcinoembryonic antigen%Combined detection
目的:探讨联合检测血清糖类抗原(CA)15-3、CA125、癌胚抗原(CEA)对乳腺癌的诊断价值。方法对112例乳腺癌患者和49例乳腺良性疾病患者进行血清CA15-3、CA125、CEA联合检测。比较2组患者及乳腺癌组不同临床分期患者3种肿瘤标志物含量和阳性率,并比较3种肿瘤标志物联合与单项检测对乳腺癌的诊断效能。结果乳腺癌组血清CA15-3、CA125及CEA水平和阳性率高于乳腺良性疾病组(P<0.05);乳腺癌Ⅲ~Ⅳ期患者血清CA15-3、CA125及CEA水平和阳性率高于Ⅰ~Ⅱ期患者(P<0.05);乳腺癌患者肿瘤标志物联合检测阳性率高于任何一种单项检测;联合检测提高了Ⅰ~Ⅱ期和Ⅲ~Ⅳ期患者的阳性率,Ⅰ~Ⅱ期患者提高幅度较大;3种肿瘤标志物联合检测提高了乳腺癌患者单项检测的敏感性、准确度和阴性预测值,但特异性和阳性预测值稍降低。结论 CA15-3、CA125、CEA联合检测可弥补单项检测的不足,对于肿瘤的早期诊断、临床分期具有重要意义。
目的:探討聯閤檢測血清糖類抗原(CA)15-3、CA125、癌胚抗原(CEA)對乳腺癌的診斷價值。方法對112例乳腺癌患者和49例乳腺良性疾病患者進行血清CA15-3、CA125、CEA聯閤檢測。比較2組患者及乳腺癌組不同臨床分期患者3種腫瘤標誌物含量和暘性率,併比較3種腫瘤標誌物聯閤與單項檢測對乳腺癌的診斷效能。結果乳腺癌組血清CA15-3、CA125及CEA水平和暘性率高于乳腺良性疾病組(P<0.05);乳腺癌Ⅲ~Ⅳ期患者血清CA15-3、CA125及CEA水平和暘性率高于Ⅰ~Ⅱ期患者(P<0.05);乳腺癌患者腫瘤標誌物聯閤檢測暘性率高于任何一種單項檢測;聯閤檢測提高瞭Ⅰ~Ⅱ期和Ⅲ~Ⅳ期患者的暘性率,Ⅰ~Ⅱ期患者提高幅度較大;3種腫瘤標誌物聯閤檢測提高瞭乳腺癌患者單項檢測的敏感性、準確度和陰性預測值,但特異性和暘性預測值稍降低。結論 CA15-3、CA125、CEA聯閤檢測可瀰補單項檢測的不足,對于腫瘤的早期診斷、臨床分期具有重要意義。
목적:탐토연합검측혈청당류항원(CA)15-3、CA125、암배항원(CEA)대유선암적진단개치。방법대112례유선암환자화49례유선량성질병환자진행혈청CA15-3、CA125、CEA연합검측。비교2조환자급유선암조불동림상분기환자3충종류표지물함량화양성솔,병비교3충종류표지물연합여단항검측대유선암적진단효능。결과유선암조혈청CA15-3、CA125급CEA수평화양성솔고우유선량성질병조(P<0.05);유선암Ⅲ~Ⅳ기환자혈청CA15-3、CA125급CEA수평화양성솔고우Ⅰ~Ⅱ기환자(P<0.05);유선암환자종류표지물연합검측양성솔고우임하일충단항검측;연합검측제고료Ⅰ~Ⅱ기화Ⅲ~Ⅳ기환자적양성솔,Ⅰ~Ⅱ기환자제고폭도교대;3충종류표지물연합검측제고료유선암환자단항검측적민감성、준학도화음성예측치,단특이성화양성예측치초강저。결론 CA15-3、CA125、CEA연합검측가미보단항검측적불족,대우종류적조기진단、림상분기구유중요의의。
Objective To investigate the clinical value of combined detection of serum carbohydrate antigen ( CA) 15-3,CA125,carcinoembryonic antigen ( CEA) in the diagnosis of breast cancer .Methods Serum CA15-3,CEA,and CA125 were detected in 112 patients with breast cancer and 49 patients with benign breast disease .Content and positive rates of the 3 tumor markers in the 2 groups and different stages of the breast cancer group were compared ,and value of combined detection of the 3 tumor markers and detection of single tumor marker in the diagnosis of breast cancer were compared .Results Serum level and positive rates of CA15-3,CA125 and CEA in the breast cancer group were higher than those of the breast benign disease group ( P<0.05);serum level and positive rates of CA 15-3,CA125 and CEA of stage Ⅲ~Ⅳbreast cancer were higher than those of the stageⅠ~Ⅱbreast cancer (P<0.05);combined detection of the 3 tumor markers had higher positive rates in breast cancer pa-tients than that of any single detection;Combined detection improved the positive rates of stageⅠ~Ⅱ and stage Ⅲ~Ⅳ breast cancer patients ,stageⅠ~Ⅱpatients had significant increased;combined detection of the 3 tumor markers in patients with breast cancer improved individual sensitivity ,accuracy and negative predictive value ,while reduced the specificity and positive predictive value slightly.Conclusion Combined detection of CA15-3,CA125,CEA can make up for the shortage of single detection ,and it is important for early diagnosis and clinical staging .